Article
Comparative Efficacy of Treatments for Brain Metastases from Non-Small Cell Lung Cancer without an EGFR-Mutation/ALK-Rearrangement: A Systematic Review and Network Meta-Analysis.
World neurosurgery - 1 Feb 2022
Brar Karanbir, Taslimi Shervin, Ellenbogen Yosef, Deng Jiawen, Hou Winston, Moraes Fabio Y, Glantz Michael, Zacharia Brad E, Tan Aaron, Ahluwalia Manmeet S, Khasraw Mustafa, Zadeh Gelareh, Mansouri Alireza
Abstract excerpt
INTRODUCTION: As many as 30% of patients with non-small cell lung cancer (NSCLC) will develop brain metastases (BMs) over the course of their illness. Here, we quantitatively compare the efficacy of the various emerging regimens for NSCLC BMs without a definitive targetable epidermal growth factor receptor mutation/ALK rearrangement. METHODS: We searched MEDLINE, EMBASE, Web of Science, ClinicalTrials.gov,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.